How to Appeal an Insurance Denial for Ketamine

Receiving an insurance denial for ketamine therapy — whether for Spravato or compounded oral forms — is frustrating, but it is not the end of the road. If you haven't yet submitted a prior authorization, that may be your first step. Insurance appeals succeed at meaningful rates, particularly when well-documented and strategically presented. This guide walks through every step of the appeals process.

Why Appeals Succeed

Understanding why initial denials occur helps you craft effective appeals:

Common denial reasons:

• Insufficient documentation of prior treatment failures
• Criteria not clearly met (e.g., definition of "adequate trial" disputed)
• Missing concurrent antidepressant documentation (for Spravato)
• Administrative errors (wrong code, missing information)

For patients who cannot secure insurance coverage, patient assistance programs may offer alternative pathways to affordable treatment.

• Non-formulary denial (for compounded drugs)
• "Experimental/investigational" determination

Most of these are addressable through additional documentation, clinical argument, or both. The fact that you received a denial does not necessarily mean the insurer believes your case has no merit — it often means the initial submission lacked sufficient documentation.

Understanding Your Rights

Several federal and state laws protect patients' rights to appeal insurance denials:

Affordable Care Act (ACA): Requires all non-grandfathered plans to provide:

• Internal appeal process
• External appeal process
• Expedited appeals for urgent situations

ERISA (for employer-sponsored plans): Mandates appeal rights and provides legal remedies for wrongful denials.

Mental Health Parity and Addiction Equity Act (MHPAEA): Requires that mental health treatment appeals be handled with the same standards as medical/surgical treatment appeals. If a plan appeals medical denials using one standard, it cannot use more restrictive standards for mental health appeals.

State Laws: Many states have additional consumer protections beyond federal requirements, including mandatory timelines, right to expedited review, and right to an independent external review.

Step 1: Understand the Denial

Before appealing, understand exactly why you were denied. Request:

1. Written denial notice: Required by law; must state the specific reason for denial, citing the specific plan provision or clinical criteria not met
2. Clinical Coverage Policy: The written policy the insurer used to make the decision
3. Evidence basis: What clinical evidence or guidelines the insurer relied upon

Read the denial carefully. Match the denial reason to the specific documentation you can provide to address it.

Step 2: The Internal Appeal

Every health plan must have an internal appeal process. This is your first formal challenge to the denial.

Timeline

• Standard internal appeal: Decision within 30 days (for coverage not yet received) or 60 days (for coverage already received/concurrent)
• Expedited appeal: Decision within 72 hours if delayed appeals would jeopardize health or ability to regain function
• Post-service appeal: Decision within 60 days of the request

If you are being denied Spravato during an active severe depression with suicidality, request expedited review — the insurer must respond within 72 hours.

Building Your Appeal Package

An effective internal appeal includes:

1. Appeal Letter

Structure your appeal letter as follows:

Header: Patient name, member ID, date of service, claim or PA reference number, date of denial

Opening statement: "We are writing to appeal the denial of [treatment] for [patient name], denied on [date] for [stated reason]."

Clinical history summary: Brief but thorough summary of the patient's depression history, severity, impact on function

Prior treatment history: Enumerate each antidepressant trial with drug name, dose, duration, outcome, and reason for discontinuation — in table format for clarity

Why the denial criteria are incorrect: Directly address each reason stated in the denial letter. If they said "insufficient prior treatment failures," document your prior failures in detail. If they said "not medically necessary," provide clinical evidence of necessity.

Clinical literature: Cite relevant published clinical evidence for the treatment's efficacy (relevant clinical trial publications, clinical practice guidelines)

Request: Clearly state what you are requesting: approval of [specific treatment] for [number of sessions/duration]

2. Supporting Clinical Documentation

Attach:

• Current treating psychiatrist/prescriber's letter of medical necessity
• Clinical notes documenting diagnosis and treatment course
• Validated depression rating scale scores (PHQ-9, MADRS)
• Pharmacy or prescriber records of prior antidepressant trials
• Relevant research publications supporting the treatment
• Any prior approval or authorization documentation for related treatments

3. Peer-to-Peer Review Request

Simultaneously with the written appeal, your prescriber should request a peer-to-peer review — a direct phone call with the insurer's medical director reviewing the case. This is separate from but complementary to the written appeal.

In a peer-to-peer review:

• Your prescriber speaks directly with the insurer's physician reviewer
• Clinical nuances can be explained that are difficult to convey in documentation alone
• The urgency and clinical complexity of the situation can be communicated
• Peer-to-peer reviews overturn denials at meaningful rates — often 40–60% depending on the condition and insurer

Your role: Ensure your prescriber knows about the peer-to-peer option, provide them with all relevant documentation in advance of the call, and follow up to ensure the call occurs within the appeal timeline.

Step 3: External Independent Review

If the internal appeal is denied, you have the right to request an external independent review (also called external appeal or external review). This is a review by an organization independent of your insurance company.

Key facts about external review:

• Required by ACA for most plans
• Reviewer is a qualified independent review organization (IRO) contracted by your state
• Decision is typically binding on the insurer
• Must be requested within 4 months of the internal appeal denial
• Cost to you: $0–$25 depending on state (some states have no cost)
• Timeline: Standard decision within 45 days; expedited within 72 hours

Success rates: External review success rates for medical and mental health appeals vary by condition and insurer, but some studies report that patients win external reviews in 30–50% of cases where they proceed to this step.

How to request external review:

• Your denial notice must include instructions for requesting external review
• Contact your state insurance commissioner's office if you cannot find the information
• In employer-sponsored plans, ERISA external review may apply with different processes

Step 4: State Insurance Commissioner Complaint

Filing a complaint with your state insurance commissioner is appropriate when:

• The insurer has not followed required appeal timelines
• You believe the denial violates mental health parity
• The insurer has acted in bad faith
• You have exhausted internal processes and want regulatory attention

This is not a formal appeal but a regulatory complaint. The commissioner's office investigates and can require the insurer to explain their decision and potentially reverse it.

Step 5: Legal Action

For employer-sponsored (ERISA) plans, if internal and external appeals fail, you have the right to file a civil lawsuit under ERISA Section 502(a). This is a last resort requiring an attorney specializing in ERISA litigation.

For state-regulated (non-ERISA) plans, state consumer protection laws and insurance regulations may provide additional legal remedies.

Mental Health Parity Appeals

For ketamine therapy denials specifically, the Mental Health Parity Act (MHPAEA) argument can be powerful:

The argument: If your plan covers other treatments that are similarly evidence-based but not FDA-approved for specific psychiatric conditions (common in psychiatry — many drugs are used off-label), then denying ketamine based on off-label status may violate parity. Similarly, if the plan applies more restrictive step therapy or prior authorization requirements to mental health treatments than comparable medical treatments, this may violate parity.

Request a parity analysis: Ask your insurer to provide a "Non-Quantitative Treatment Limitation" (NQTL) analysis comparing how they apply their criteria to mental health vs. medical benefits. Discrepancies revealed in this analysis can support a parity violation argument.

Report suspected violations: CMS and DOL oversee MHPAEA compliance and accept complaints about suspected violations.

Practical Tips for Successful Appeals

1. Act immediately: Appeal deadlines are strict. Begin the process the day you receive a denial.
2. Be specific: Vague appeals fail. Address each denial reason specifically with specific evidence.
3. Involve your prescriber actively: Their clinical expertise is your strongest asset.
4. Use the peer-to-peer process: This is often the single most effective intervention.
5. Document everything: Keep copies of all correspondence, note dates and names of all phone calls.
6. Consider a patient advocate: Professional patient advocates specialize in insurance appeals and can significantly improve success rates.
7. Don't give up after one denial: Multiple appeals are expected and often succeed.

References

• StatPearls: Ketamine — Comprehensive clinical reference on ketamine pharmacology, mechanisms of action, and therapeutic applications
• PubChem: Ketamine Compound Summary — NCBI chemical database entry with ketamine molecular data, pharmacokinetics, and bioactivity profiles
• MedlinePlus: Ketamine — National Library of Medicine consumer drug information on ketamine including uses, proper administration, and precautions
• MedlinePlus: Esketamine Nasal Spray — National Library of Medicine drug information on FDA-approved Spravato (esketamine) for treatment-resistant depression
• Healthcare.gov: Understanding Costs — Federal marketplace resource explaining insurance terminology and out-of-pocket healthcare costs